Closed System Drug Transfer Device (CSTD) Market By Type (Membrane to membrane, Needleless) , By Component (Barrier type CSTDs, Air cleaning CSTDs) By End user (Hospitals and Clinics, Oncology Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Closed System Drug Transfer Device (CSTD) Market
The closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.
A closed system drug transfer device (CSTD) is a medical equipment which prevents contact between the inner environment of a system and the outer surroundings. CSTD forbids the entry of contaminants from the surroundings into medical equipment or system and prohibits the evasion of hazardous chemicals or vapors from the system to the external environment. These devices are critical for the safety of both patients and the medical professionals working in a hospital setting from probable cytotoxic or teratogenic agents.
With increasing prevalence of cancer and other chronic diseases, the adoption of CSTD is becoming essential in most healthcare settings, hence driving the growth of the market. In addition, implementation of regulatory mandates by several governing bodies such as Occupational Safety and Health Administration and the United States Pharmacopeia is boosting the demand for CSTDs. The integration of CSTDs with automation & robotics is a trend gaining significant prominence in pharmacies and drug preparation facilities to ensure efficient handling and usage of hazardous chemicals.
However, technical hurdles associated with the compatibility of CSTDs with diverse sizes of syringes, drug vials, and infusion systems pose the risk of malfunctions and hamper the development of the closed system drug transfer device (CSTD) market. Moreover, the usage of CSTDs requires high proficiency and specialized training, which is usually resource-intensive and laborious. This hampers the market growth. Contrarily, the exponentially rising cases of cancer are anticipated to present lucrative growth opportunities for the market. The number of cancer cases are expected to increase at the rate of 30 million new cases per year by 2040, thereby necessitating the use of CSTDs in hospitals.
Segment Review
The closed system drug transfer device (CSTD) market is segmented into type, component, end user, and region. On the basis of type, the market is bifurcated into membrane to membrane and needleless. Depending on component, it is divided into barrier type CSTDs and air cleaning CSTDs. As per end user, it is categorized into hospitals & clinics, oncology centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the membrane to membrane segment dominates the closed system drug transfer device (CSTD) market.
As per end user, the hospitals & clinics segment holds a high share of the market.
Region wise, North America is the major revenue generator of the closed system drug transfer device (CSTD) market.
Competition Analysis
The key players operating in the global closed system drug transfer device (CSTD) market include B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd., Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd., and Yukon Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Key Market Segments
By Component
Barrier type CSTDs
Air cleaning CSTDs
By End User
Hospitals and Clinics
Oncology Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
By Type
Membrane to membrane
Needleless
Key Market Players
B. Braun Holding GmbH & Co. KG
Baxter International
Becton, Dickinson and Company
Caragen Ltd.
Corvida Medical
Equashield
FIMI Opportunity Funds (Simplivia Healthcare)
ICU Medical
JCB Co Ltd.
Yukon Medical
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Membrane To Membrane
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Needleless
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Component
- 5.2. Barrier Type CSTDs
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Air Cleaning CSTDs
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals And Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Oncology Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Component
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Closed System Drug Transfer Device (CSTD) Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Component
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Closed System Drug Transfer Device (CSTD) Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Component
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Closed System Drug Transfer Device (CSTD) Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Component
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Component
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Closed System Drug Transfer Device (CSTD) Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Component
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Closed System Drug Transfer Device (CSTD) Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Component
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Closed System Drug Transfer Device (CSTD) Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Component
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Closed System Drug Transfer Device (CSTD) Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Component
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Closed System Drug Transfer Device (CSTD) Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Component
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Closed System Drug Transfer Device (CSTD) Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Component
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Component
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Closed System Drug Transfer Device (CSTD) Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Component
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Closed System Drug Transfer Device (CSTD) Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Component
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Closed System Drug Transfer Device (CSTD) Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Component
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Closed System Drug Transfer Device (CSTD) Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Component
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Closed System Drug Transfer Device (CSTD) Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Component
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Component
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Component
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Closed System Drug Transfer Device (CSTD) Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Component
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Closed System Drug Transfer Device (CSTD) Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Component
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Component
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Closed System Drug Transfer Device (CSTD) Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Component
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. B. Braun Holding GmbH And Co. KG
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Baxter International
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Becton, Dickinson And Company
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Caragen Ltd.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Corvida Medical
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Equashield
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. FIMI Opportunity Funds (Simplivia Healthcare)
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. ICU Medical
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. JCB Co Ltd.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Yukon Medical
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR MEMBRANE TO MEMBRANE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR NEEDLELESS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 5. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR BARRIER TYPE CSTDS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR AIR CLEANING CSTDS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 8. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR ONCOLOGY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 13. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 14. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 16. U.S. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 17. U.S. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 18. U.S. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. CANADA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 20. CANADA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. MEXICO CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 23. MEXICO CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 24. MEXICO CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 26. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 27. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. FRANCE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 30. FRANCE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 31. FRANCE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. GERMANY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 33. GERMANY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 34. GERMANY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 35. ITALY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 36. ITALY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 37. ITALY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 38. SPAIN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 39. SPAIN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 40. SPAIN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. UK CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 42. UK CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 43. UK CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. REST OF EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 45. REST OF EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 46. REST OF EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 48. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 49. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. CHINA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 52. CHINA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 53. CHINA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 55. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 56. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. INDIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 58. INDIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 59. INDIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. SOUTH KOREA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 61. SOUTH KOREA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 62. SOUTH KOREA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. AUSTRALIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 64. AUSTRALIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 65. AUSTRALIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. REST OF ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 67. REST OF ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 68. REST OF ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 69. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 70. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 71. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. BRAZIL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 74. BRAZIL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 75. BRAZIL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 76. SOUTH AFRICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 77. SOUTH AFRICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 78. SOUTH AFRICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 79. SAUDI ARABIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 80. SAUDI ARABIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 81. SAUDI ARABIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 82. REST OF LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 83. REST OF LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
- TABLE 84. REST OF LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 85. B. BRAUN HOLDING GMBH AND CO. KG: KEY EXECUTIVES
- TABLE 86. B. BRAUN HOLDING GMBH AND CO. KG: COMPANY SNAPSHOT
- TABLE 87. B. BRAUN HOLDING GMBH AND CO. KG: OPERATING SEGMENTS
- TABLE 88. B. BRAUN HOLDING GMBH AND CO. KG: PRODUCT PORTFOLIO
- TABLE 89. B. BRAUN HOLDING GMBH AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. BAXTER INTERNATIONAL: KEY EXECUTIVES
- TABLE 91. BAXTER INTERNATIONAL: COMPANY SNAPSHOT
- TABLE 92. BAXTER INTERNATIONAL: OPERATING SEGMENTS
- TABLE 93. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
- TABLE 94. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 96. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 97. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 98. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 99. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. CARAGEN LTD.: KEY EXECUTIVES
- TABLE 101. CARAGEN LTD.: COMPANY SNAPSHOT
- TABLE 102. CARAGEN LTD.: OPERATING SEGMENTS
- TABLE 103. CARAGEN LTD.: PRODUCT PORTFOLIO
- TABLE 104. CARAGEN LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. CORVIDA MEDICAL: KEY EXECUTIVES
- TABLE 106. CORVIDA MEDICAL: COMPANY SNAPSHOT
- TABLE 107. CORVIDA MEDICAL: OPERATING SEGMENTS
- TABLE 108. CORVIDA MEDICAL: PRODUCT PORTFOLIO
- TABLE 109. CORVIDA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110. EQUASHIELD: KEY EXECUTIVES
- TABLE 111. EQUASHIELD: COMPANY SNAPSHOT
- TABLE 112. EQUASHIELD: OPERATING SEGMENTS
- TABLE 113. EQUASHIELD: PRODUCT PORTFOLIO
- TABLE 114. EQUASHIELD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : KEY EXECUTIVES
- TABLE 116. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : COMPANY SNAPSHOT
- TABLE 117. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : OPERATING SEGMENTS
- TABLE 118. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : PRODUCT PORTFOLIO
- TABLE 119. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 120. ICU MEDICAL: KEY EXECUTIVES
- TABLE 121. ICU MEDICAL: COMPANY SNAPSHOT
- TABLE 122. ICU MEDICAL: OPERATING SEGMENTS
- TABLE 123. ICU MEDICAL: PRODUCT PORTFOLIO
- TABLE 124. ICU MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 125. JCB CO LTD.: KEY EXECUTIVES
- TABLE 126. JCB CO LTD.: COMPANY SNAPSHOT
- TABLE 127. JCB CO LTD.: OPERATING SEGMENTS
- TABLE 128. JCB CO LTD.: PRODUCT PORTFOLIO
- TABLE 129. JCB CO LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 130. YUKON MEDICAL: KEY EXECUTIVES
- TABLE 131. YUKON MEDICAL: COMPANY SNAPSHOT
- TABLE 132. YUKON MEDICAL: OPERATING SEGMENTS
- TABLE 133. YUKON MEDICAL: PRODUCT PORTFOLIO
- TABLE 134. YUKON MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
- FIGURE 10. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SEGMENTATION, BY TYPE
- FIGURE 11. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR MEMBRANE TO MEMBRANE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR NEEDLELESS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SEGMENTATION, BY COMPONENT
- FIGURE 14. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR BARRIER TYPE CSTDS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR AIR CLEANING CSTDS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SEGMENTATION, BY END USER
- FIGURE 17. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR ONCOLOGY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 24. COMPETITIVE DASHBOARD
- FIGURE 25. COMPETITIVE HEATMAP: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
- FIGURE 26. TOP PLAYER POSITIONING, 2023
- FIGURE 27. B. BRAUN HOLDING GMBH AND CO. KG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 28. B. BRAUN HOLDING GMBH AND CO. KG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. B. BRAUN HOLDING GMBH AND CO. KG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. BAXTER INTERNATIONAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. BAXTER INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. BAXTER INTERNATIONAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. CARAGEN LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. CARAGEN LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. CARAGEN LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. CORVIDA MEDICAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. CORVIDA MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. CORVIDA MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. EQUASHIELD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. EQUASHIELD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. EQUASHIELD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. ICU MEDICAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. ICU MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. ICU MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. JCB CO LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. JCB CO LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. JCB CO LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. YUKON MEDICAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. YUKON MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. YUKON MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook